Here, in a larger cohort of subjects including both volunteers and cancer patients, CD4+ cells segregated distally from the CD14+HLA-DRlo/neg phenotype and were inversely correlated to the percentage of CD14+HLA-DRlo/neg monocytes (p < 0.001; Spearman r = -0.3244). The gene discussed is CD4; the disease is cancer.